AI in Life Sciences Market, 2026-2040 Industry Trends and Global Forecasts - IBM, IQVIA and Oracle Lead Data Platforms While Roche, Pfizer and AI Startups Accelerat…

AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast ...
pharmaphorum

Changing Faces: Pharma and biotech, February 2026

The pharmaceutical and biotech sectors have seen a flurry of executive movement this month, with leadership changes spanning global giants, clinical-stage biotechs, and specialist pharma companies ...
The Street Journal

NAFDAC warn healthcare providers, public about circulation of counterfeit Avastin 400mg vials

The National Agency for Food and Drug Administration and Control (NAFDAC) on Thursday, March 12, warned healthcare providers and the public about the circulation of confirmed counterfeit Avastin 400mg ...
AllAfrica on MSN

NAFDAC warns of counterfeit Avastin cancer drug circulating in Nigeria

Avastin, also known as bevacizumab, is a cancer medicine used in the treatment of recurrent glioblastoma in adults.The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted ...
NewsBytes

AI won't cut drug development time from 15 to 3 years

Bayer CEO, Bill Anderson, warns against overestimating AI's ability to significantly reduce drug development timelines from 15 years to just 3.